Concepedia
Statistics
Publications
6
Citations
339
H-Index
Active since
2014
Affiliations
NYU Langone Health(Current)
Ariadne Diagnostics (United States)
Dana-Farber Cancer Institute
Takeda (Japan)
Francois Gonzalvez is an author at NYU Langone Health specializing in pharmacology, medicine, and oncology.
Publications per year
2014–2023
Mobocertinib (TAK-788): A Targeted Inhibitor of <i>EGFR</i> Exon 20 Insertion Mutants in Non–Small Cell Lung Cancer
Francois Gonzalvez, Sylvie Vincent, Theresa E. Baker et al. · Cancer Discovery · 2021 · 195 citations · Full text
Medicine, Oncology, Pharmacology +15
Targeting <i>HER2</i> Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib
Han Han, Shuai Li, Ting Chen et al. · Cancer Research · 2021 · 57 citations · Full text
Medicine, Oncology, Pharmacology +16
Abstract 2644: AP32788, a potent, selective inhibitor of EGFR and HER2 oncogenic mutants, including exon 20 insertions, in preclinical models
Francois Gonzalvez, Xiaotian Zhu, Wei‐Sheng Huang et al. · Cancer Research · 2016 · 29 citations
Medicine, Oncology, Pharmacology +17
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non–small cell lung cancer
Wei‐Sheng Huang, Feng Li, Yongjin Gong et al. · Bioorganic & Medicinal Chemistry Letters · 2022 · 25 citations · Full text
Medicine, Oncology, Pharmacology +13
Comparative TKI Profiling Analyses to Explore Potential Mechanisms of Ponatinib-Associated Arterial Thrombotic Events
Victor M. Rivera, Justin R. Pritchard, Francois Gonzalvez et al. · Blood · 2014 · 18 citations
Medicine, Hematology, Pharmacology +16
1–5 of 6